Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

Trixeo approved in the EU as first triple combination maintenance therapy for asthma in patients aged 12 and older


Novo Nordisk and Anthropic to team up on accelerating drug discovery through Claude


Körber certifies ZETA’s INOSIM Foresight for PAS X MES data integration


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Continuous Manufacturing as a Default Platform for Oral Solid Drug Products

Presented by Lawrence De Belder, Senior Principal Engineer Continuous Manufacturing at Johnson and Johnson and Bob Lenich, Director of Life Sciences Business at Emerson
19th May 2020


Advances in Mass Spectrometry for the Analysis and Bioanalysis of Antibody Drug Conjugates

Presented by Arnaud Delobel, PhD, R&D Director at Quality Assistance sa
12th September 2017


Future Trends To Control Risks From Extractables and Leachables

Presented by Jason Creasey, Managing Director at Maven E&L Ltd and Kathleen Lava PhD – E&L Expert Nelson Labs Europe
09th February 2021


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia